Hi-Clearance Inc. (TPEX:1788)
137.00
+0.50 (0.37%)
Jan 22, 2026, 1:30 PM CST
Hi-Clearance Market Cap
Hi-Clearance has a market cap or net worth of 6.08 billion as of January 21, 2026. Its market cap has decreased by -1.80% in one year.
Market Cap
6.08B
Enterprise Value
6.77B
Revenue
4.19B
Ranking
n/a
PE Ratio
17.39
Stock Price
137.00
Market Cap Chart
Since October 18, 2004, Hi-Clearance's market cap has increased from 875.00M to 6.08B, an increase of 594.53%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.05B | -0.37% |
| Dec 31, 2025 | 6.08B | -2.15% |
| Dec 31, 2024 | 6.21B | 2.95% |
| Dec 29, 2023 | 6.03B | 3.39% |
| Dec 30, 2022 | 5.84B | -0.35% |
| Dec 30, 2021 | 5.86B | 30.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |